Structure Therapeutics Inc. — All Filings
239 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
10-Q/A
144
3
4
4/A
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DRS
DRS/A
DRSLTR
EFFECT
F-6
NT 10-Q
S-1
S-1/A
S-1MEF
S-3ASR
S-8
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | — | 0001415889-25-018218 | Jun 25, 2025 | Jun 23, 2025 |
| 8-K | FORM 8-K | 0001104659-25-062576 | Jun 25, 2025 | Jun 23, 2025 |
| 4 | — | 0001415889-25-018213 | Jun 25, 2025 | Jun 23, 2025 |
| 4 | — | 0001415889-25-018217 | Jun 25, 2025 | Jun 23, 2025 |
| 4 | — | 0001415889-25-018214 | Jun 25, 2025 | Jun 23, 2025 |
| 4 | — | 0001415889-25-018215 | Jun 25, 2025 | Jun 23, 2025 |
| 4 | — | 0001415889-25-018216 | Jun 25, 2025 | Jun 23, 2025 |
| SCHEDULE 13G/A | — | 0001172661-25-001964 | May 15, 2025 | — |
| SCHEDULE 13G/A | — | 0001422848-25-000060 | May 13, 2025 | — |
| 8-K | FORM 8-K | 0001104659-25-046149 | May 8, 2025 | — |
| 10-Q | 10-Q | 0001558370-25-006989 | May 8, 2025 | Mar 31, 2025 |
| DEF 14A | DEF 14A | 0001104659-25-038675 | Apr 24, 2025 | Jun 23, 2025 |
| ARS | ARS | 0001104659-25-038690 | Apr 24, 2025 | Dec 31, 2024 |
| 4 | — | 0001415889-25-008555 | Mar 18, 2025 | Mar 15, 2025 |
| 4 | — | 0001415889-25-008552 | Mar 18, 2025 | Mar 15, 2025 |
| 4 | — | 0001415889-25-008550 | Mar 18, 2025 | Mar 15, 2025 |
| 4 | — | 0001415889-25-008553 | Mar 18, 2025 | Mar 15, 2025 |
| 4 | — | 0001415889-25-008554 | Mar 18, 2025 | Mar 15, 2025 |
| 4 | — | 0001415889-25-008551 | Mar 18, 2025 | Mar 15, 2025 |
| S-8 | FORM S-8 | 0001104659-25-018327 | Feb 27, 2025 | — |
| 8-K | FORM 8-K | 0001104659-25-018275 | Feb 27, 2025 | — |
| 10-K | 10-K | 0001558370-25-001826 | Feb 27, 2025 | Dec 31, 2024 |
| 4 | 4 | 0000950170-25-016705 | Feb 10, 2025 | Feb 6, 2025 |
| SCHEDULE 13G | — | 0001172661-25-000177 | Jan 13, 2025 | — |
| 8-K | FORM 8-K | 0001104659-24-129378 | Dec 17, 2024 | — |
| SC 13G/A | STRUCTURE THERAPEUTICS INC. | 0000902664-24-006524 | Nov 14, 2024 | — |
| SC 13G/A | SC 13G/A | 0001104659-24-119301 | Nov 14, 2024 | — |
| 8-K | FORM 8-K | 0001104659-24-117691 | Nov 13, 2024 | — |
| 10-Q | 10-Q | 0001558370-24-015531 | Nov 13, 2024 | Sep 30, 2024 |
| SC 13G | SEC SCHEDULE 13G | 0001422848-24-000335 | Nov 12, 2024 | — |
| SC 13G/A | — | 0000315066-24-002903 | Nov 12, 2024 | — |
| SC 13G/A | SEC SCHEDULE 13G | 0000902219-24-000453 | Nov 8, 2024 | — |
| 4 | — | 0001415889-24-023794 | Sep 20, 2024 | Sep 18, 2024 |
| 3 | — | 0001415889-24-023793 | Sep 20, 2024 | Sep 18, 2024 |
| 3 | — | 0001415889-24-023790 | Sep 20, 2024 | Sep 18, 2024 |
| 4 | — | 0001415889-24-023791 | Sep 20, 2024 | Sep 18, 2024 |
| 8-K | FORM 8-K | 0001104659-24-100668 | Sep 17, 2024 | Sep 12, 2024 |
| 4 | — | 0001415889-24-022457 | Aug 28, 2024 | Aug 26, 2024 |
| 3 | — | 0001415889-24-022456 | Aug 28, 2024 | Aug 26, 2024 |
| 8-K | FORM 8-K | 0001104659-24-093434 | Aug 27, 2024 | Aug 24, 2024 |
| 8-K | FORM 8-K | 0001104659-24-087275 | Aug 8, 2024 | — |
| 10-Q | 10-Q | 0001558370-24-011616 | Aug 8, 2024 | Jun 30, 2024 |
| 4 | — | 0001415889-24-018325 | Jun 27, 2024 | Jun 25, 2024 |
| 4 | — | 0001415889-24-018324 | Jun 27, 2024 | Jun 25, 2024 |
| 4 | — | 0001415889-24-018326 | Jun 27, 2024 | Jun 25, 2024 |
| 8-K | FORM 8-K | 0001104659-24-075724 | Jun 27, 2024 | Jun 25, 2024 |
| 4 | — | 0001415889-24-018327 | Jun 27, 2024 | Jun 25, 2024 |
| 4 | — | 0001415889-24-018328 | Jun 27, 2024 | Jun 25, 2024 |
| 4 | — | 0001415889-24-017040 | Jun 14, 2024 | Jun 12, 2024 |
| 3 | 3 | 0000950170-24-072703 | Jun 13, 2024 | Jun 6, 2024 |